Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Number of holders
-
49
-
Total 13F shares, excl. options
-
1,901,736
-
Shares change
-
+38,807
-
Total reported value, excl. options
-
$104,884,746
-
Value change
-
+$2,251,433
-
Number of buys
-
21
-
Number of sells
-
23
-
Price
-
$55.14
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2017
As of 31 Mar 2017 VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) had 49 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,901,736 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, CITIGROUP INC, UBS Group AG, RAYMOND JAMES & ASSOCIATES, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, STUYVESANT CAPITAL MANAGEMENT, MAYO INVESTMENT ADVISERS LLC, LPL Financial LLC, and CITADEL ADVISORS LLC.
This table shows 49 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.